Cargando…

The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis

The contribution of the immune system to idiopathic pulmonary fibrosis (IPF) remains poorly understood. While most sources agree that IPF does not result from a primary immunopathogenic mechanism, evidence gleaned from animal modeling and human studies suggests that innate and adaptive immune proces...

Descripción completa

Detalles Bibliográficos
Autores principales:	Desai, Omkar, Winkler, Julia, Minasyan, Maksym, Herzog, Erica L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869935/ https://www.ncbi.nlm.nih.gov/pubmed/29616220 http://dx.doi.org/10.3389/fmed.2018.00043

Ejemplares similares

Pirfenidone treatment of idiopathic pulmonary fibrosis
por: Gan, Ye, et al.
Publicado: (2011)

Inflammatory Leukocyte Phenotypes Correlate with Disease Progression in Idiopathic Pulmonary Fibrosis
por: Moore, Bethany B., et al.
Publicado: (2014)

Idiopathic pulmonary fibrosis and the role of genetics in the era of precision medicine
por: Alonso-Gonzalez, Aitana, et al.
Publicado: (2023)

The Management of Patients With Idiopathic Pulmonary Fibrosis
por: Spagnolo, Paolo, et al.
Publicado: (2018)

Telomere Dysfunction in Idiopathic Pulmonary Fibrosis
por: Zhang, Kexiong, et al.
Publicado: (2021)

Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyrios, et al.
Publicado: (2018)

Insights Into Development and Progression of Idiopathic Pulmonary Fibrosis From Single Cell RNA Studies
por: Nemeth, Julia, et al.
Publicado: (2020)

Treatment of Idiopathic Pulmonary Fibrosis
por: Abuserewa, Sherif T, et al.
Publicado: (2021)

Impact of Depression on Patients With Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2020)

The Role of Immune Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis
por: Xu, Yahan, et al.
Publicado: (2023)

Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment
por: Kaur, Amarpreet, et al.
Publicado: (2017)

Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis
por: Tashiro, Jun, et al.
Publicado: (2017)

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management
por: Oldham, Justin M., et al.
Publicado: (2017)

Editorial: Idiopathic pulmonary fibrosis: epidemiology, prognosis and treatment
por: Caminati, Antonella, et al.
Publicado: (2023)

Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics
por: Zank, Daniel C., et al.
Publicado: (2018)

Single-cell profiling reveals immune aberrations in progressive idiopathic pulmonary fibrosis
por: Unterman, Avraham, et al.
Publicado: (2023)

Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis
por: Lancaster, Lisa, et al.
Publicado: (2020)

A role for the terminal C5-C9 complement pathway in idiopathic pulmonary fibrosis
por: Sikkeland, Liv I. B., et al.
Publicado: (2023)

Integrating Patient Perspectives into Personalized Medicine in Idiopathic Pulmonary Fibrosis
por: Moor, Catharina C., et al.
Publicado: (2017)

Diagnosis of Idiopathic Pulmonary Fibrosis “Pragmatic Challenges in Clinical Practice”
por: Tzilas, Vasilios, et al.
Publicado: (2017)

Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal?
por: Sesé, Lucile, et al.
Publicado: (2021)

Identification of diagnostic gene biomarkers related to immune infiltration in patients with idiopathic pulmonary fibrosis based on bioinformatics strategies
por: Dai, Xiangdong, et al.
Publicado: (2022)

Machine learning-based prediction of candidate gene biomarkers correlated with immune infiltration in patients with idiopathic pulmonary fibrosis
por: Zhang, Yufeng, et al.
Publicado: (2023)

Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
por: Tzouvelekis, Argyrios, et al.
Publicado: (2017)

Lung Tissue Microbiome Is Associated With Clinical Outcomes of Idiopathic Pulmonary Fibrosis
por: Yoon, Hee-Young, et al.
Publicado: (2021)

Mortality and Respiratory-Related Hospitalizations in Idiopathic Pulmonary Fibrosis Not Treated With Antifibrotics
por: Cottin, Vincent, et al.
Publicado: (2021)

Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis
por: Takei, Reoto, et al.
Publicado: (2023)

The Extent of Inflammatory Cell Infiltrate and Fibrosis in Lungs of Telomere- and Surfactant-Related Familial Pulmonary Fibrosis
por: van Batenburg, Aernoud A., et al.
Publicado: (2021)

Corrigendum: Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
por: Tzouvelekis, Argyrios, et al.
Publicado: (2018)

Idiopathic Pulmonary Fibrosis in Elderly Patients: Analysis of the INSIGHTS-IPF Observational Study
por: Leuschner, Gabriela, et al.
Publicado: (2020)

Microscopic polyangiitis initially presenting with idiopathic pulmonary fibrosis: a case report
por: Shao, Chi, et al.
Publicado: (2023)

Non-coding RNAs as Regulators of Cellular Senescence in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease
por: Omote, Norihito, et al.
Publicado: (2020)

Immune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis
por: Balestro, Elisabetta, et al.
Publicado: (2016)

Clinical relevance of circulating autoantibodies in idiopathic pulmonary fibrosis; A NAt hard to break
por: Kirgou, Paraskevi, et al.
Publicado: (2022)

Road Toward a New Model of Care for Idiopathic Pulmonary Fibrosis in the Lazio Region
por: Di Bidino, Rossella, et al.
Publicado: (2022)

Mendelian randomization study reveals the effect of idiopathic pulmonary fibrosis on the risk of erectile dysfunction
por: Zhang, Kun, et al.
Publicado: (2023)

Real world experience on the effectiveness and safety of pirfenidone in patients with idiopathic pulmonary fibrosis in Taiwan
por: Chang, Cheng-Yu, et al.
Publicado: (2023)

Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the World
por: Polke, Markus, et al.
Publicado: (2021)

The Role of Herpes Viruses in Pulmonary Fibrosis
por: Duckworth, Anna, et al.
Publicado: (2021)

A Review of Pirfenidone as an Anti-Fibrotic in Idiopathic Pulmonary Fibrosis and Its Probable Role in Other Diseases
por: Shah, Parth V, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sq6dqi0oarliudgkauu3c5sejj